Studies have indicated that oxidative stress and AMPK/PGC1α-mediated mitochondrial dysfunction are involved in the pathological alterations of in lipid metabolism associated with NAFLD (Dahlhoff et al., 2014; Yang et al., 2021). Here, PPARGC1A is linked to metabolic dysfunction-associated steatotic liver disease.